JP2024546996A5 - - Google Patents
Info
- Publication number
- JP2024546996A5 JP2024546996A5 JP2024536163A JP2024536163A JP2024546996A5 JP 2024546996 A5 JP2024546996 A5 JP 2024546996A5 JP 2024536163 A JP2024536163 A JP 2024536163A JP 2024536163 A JP2024536163 A JP 2024536163A JP 2024546996 A5 JP2024546996 A5 JP 2024546996A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21215028 | 2021-12-16 | ||
| EP21215028.8 | 2021-12-16 | ||
| EP22164796 | 2022-03-28 | ||
| EP22164796.9 | 2022-03-28 | ||
| EP22207926.1 | 2022-11-16 | ||
| EP22207926 | 2022-11-16 | ||
| PCT/EP2022/086452 WO2023111311A1 (en) | 2021-12-16 | 2022-12-16 | Discernible cell surface protein variants of cd117 for use in cell therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024546996A JP2024546996A (ja) | 2024-12-26 |
| JPWO2023111311A5 JPWO2023111311A5 (https=) | 2025-12-23 |
| JP2024546996A5 true JP2024546996A5 (https=) | 2025-12-23 |
Family
ID=84981434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024536163A Pending JP2024546996A (ja) | 2021-12-16 | 2022-12-16 | 細胞療法に使用するためのｃｄ１１７の識別可能な細胞表面タンパク質変異体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250057951A1 (https=) |
| EP (1) | EP4448573A1 (https=) |
| JP (1) | JP2024546996A (https=) |
| KR (1) | KR20240115920A (https=) |
| AU (1) | AU2022409748A1 (https=) |
| CA (1) | CA3240527A1 (https=) |
| IL (1) | IL313568A (https=) |
| MX (1) | MX2024007317A (https=) |
| WO (1) | WO2023111311A1 (https=) |
| ZA (1) | ZA202405110B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4540287A1 (en) * | 2022-06-20 | 2025-04-23 | CRISPR Therapeutics AG | Chimeric antigen receptor specific to cd117 |
| KR20250034296A (ko) * | 2022-07-07 | 2025-03-11 | 씨메이오 테라퓨틱스 아게 | Cd117을 표적화하는 항체 |
| WO2025231071A1 (en) * | 2024-05-01 | 2025-11-06 | Beam Therapeutics Inc. | Compositions and methods for cell conditioning |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0578774T3 (da) | 1991-04-05 | 1999-04-26 | Univ Washington | Monoklonale antistoffer mod stamcellefaktor-receptorer |
| TWI395754B (zh) | 2006-04-24 | 2013-05-11 | Amgen Inc | 人類化之ｃ-ｋｉｔ抗體 |
| WO2015050959A1 (en) | 2013-10-01 | 2015-04-09 | Yale University | Anti-kit antibodies and methods of use thereof |
| US10786578B2 (en) | 2014-08-05 | 2020-09-29 | Novartis Ag | CKIT antibody drug conjugates |
| US11499168B2 (en) | 2016-04-25 | 2022-11-15 | Universitat Basel | Allele editing and applications thereof |
| AU2017355218B2 (en) | 2016-11-02 | 2024-02-22 | Universität Basel | Immunologically discernible cell surface variants for use in cell therapy |
| SG11201907870VA (en) | 2017-02-28 | 2019-09-27 | Vor Biopharma Inc | Compositions and methods for inhibition of lineage specific proteins |
| TWI687227B (zh) * | 2017-10-03 | 2020-03-11 | 生倍科技股份有限公司 | 用於t細胞免疫療法之組合及其用途 |
| CA3079215A1 (en) * | 2017-10-24 | 2019-05-02 | Magenta Therapeutics, Inc. | Compositions and methods for the depletion of cd117+ cells |
| CA3079897A1 (en) | 2017-10-24 | 2019-05-02 | Magenta Therapeutics, Inc. | Compositions and methods for the depletion of cd117+ cells |
| US12378318B2 (en) * | 2018-08-08 | 2025-08-05 | Dragonfly Therapeutics, Inc. | Proteins binding NKG2D, CD16 and a tumor-associated antigen |
| CN119684457A (zh) | 2018-11-26 | 2025-03-25 | 四十七有限责任公司 | 针对c-kit的人源化抗体 |
| JP2022529727A (ja) * | 2019-04-24 | 2022-06-23 | マジェンタ セラピューティクス インコーポレイテッド | Ａｎｔｉ－ｃｄ１１７ とその使用 |
| US20230017979A1 (en) | 2019-08-29 | 2023-01-19 | Beam Therapeutics Inc. | Compositions and methods for non-toxic conditioning |
-
2022
- 2022-12-16 WO PCT/EP2022/086452 patent/WO2023111311A1/en not_active Ceased
- 2022-12-16 JP JP2024536163A patent/JP2024546996A/ja active Pending
- 2022-12-16 MX MX2024007317A patent/MX2024007317A/es unknown
- 2022-12-16 EP EP22843648.1A patent/EP4448573A1/en active Pending
- 2022-12-16 KR KR1020247023745A patent/KR20240115920A/ko active Pending
- 2022-12-16 AU AU2022409748A patent/AU2022409748A1/en active Pending
- 2022-12-16 US US18/719,780 patent/US20250057951A1/en active Pending
- 2022-12-16 IL IL313568A patent/IL313568A/en unknown
- 2022-12-16 CA CA3240527A patent/CA3240527A1/en active Pending
-
2024
- 2024-06-28 ZA ZA2024/05110A patent/ZA202405110B/en unknown